Structures by: Silva M. A.
Total: 11
C13H17N3O
C13H17N3O
Organic & biomolecular chemistry (2004) 2, 8 1258-1265
a=15.5820(9)Å b=9.9509(6)Å c=7.9189(5)Å
α=90.00° β=97.128(3)° γ=90.00°
C13H17N3O
C13H17N3O
Organic & biomolecular chemistry (2004) 2, 8 1258-1265
a=5.84160(10)Å b=6.9482(2)Å c=31.7123(12)Å
α=86.9810(10)° β=89.7330(10)° γ=68.6350(10)°
C13H17N3O1
C13H17N3O1
Organic & biomolecular chemistry (2004) 2, 8 1258-1265
a=12.610(3)Å b=12.464(3)Å c=16.763(3)Å
α=90° β=107.01(3)° γ=90°
C28H46N6P4S2
C28H46N6P4S2
Dalton transactions (Cambridge, England : 2003) (2005) 10 1764-1773
a=9.0091(18)Å b=9.3028(19)Å c=20.968(4)Å
α=87.66(3)° β=89.25(3)° γ=79.64(3)°
C20H30N4P2S2
C20H30N4P2S2
Dalton transactions (Cambridge, England : 2003) (2005) 10 1764-1773
a=14.756(3)Å b=9.0309(18)Å c=17.947(4)Å
α=90.00° β=97.74(3)° γ=90.00°
C28H46N6O2P4
C28H46N6O2P4
Dalton transactions (Cambridge, England : 2003) (2005) 10 1764-1773
a=8.8275(18)Å b=10.307(2)Å c=10.362(2)Å
α=68.10(3)° β=73.40(3)° γ=75.00(3)°
C20H30N4O2P2
C20H30N4O2P2
Dalton transactions (Cambridge, England : 2003) (2005) 10 1764-1773
a=11.308(2)Å b=13.578(3)Å c=15.342(3)Å
α=103.49(3)° β=96.66(3)° γ=91.07(3)°
C39H54N6O8S
C39H54N6O8S
Crystal Growth & Design (2015) 15, 11 5233
a=14.633(5)Å b=9.370(5)Å c=15.966(5)Å
α=90.000(5)° β=114.871(5)° γ=90.000(5)°
C38H55BrN6O7
C38H55BrN6O7
Crystal Growth & Design (2015) 15, 11 5233
a=14.3053(7)Å b=9.7478(4)Å c=15.84700(10)Å
α=90° β=111.404(7)° γ=90°
C38H53IN6O6
C38H53IN6O6
Crystal Growth & Design (2015) 15, 11 5233
a=14.3578(7)Å b=9.4796(4)Å c=15.9818(13)Å
α=90° β=111.131(7)° γ=90°
C38H57ClN6O8
C38H57ClN6O8
Crystal Growth & Design (2015) 15, 11 5233
a=14.2750(2)Å b=9.6424(5)Å c=16.008(2)Å
α=90° β=111.617(12)° γ=90°